Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029075 · ClinicalTrials.gov registry record · NA
tACS for Neuropathic Pain Management After SCI
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06029075: Recruiting NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT06029075 is a NA study that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06029075, a NA study, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain management in people after spinal cord injury.
Primary Outcome
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."
Interventions
- DEVICE tACS Sham
- DEVICE tACS 10Hz
- DEVICE tACS 20Hz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06029075 shows while recruiting
NCT06029075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which tACS Sham is the first listed.
NCT06029075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06029075 about?
NCT06029075 is a clinical study titled "tACS for Neuropathic Pain Management After SCI". The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain management in people after spinal cord injury.
What is the current status of trial NCT06029075?
This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-09-01. Estimated completion is 2028-03-31.
What interventions are being tested in trial NCT06029075?
The interventions under investigation include: tACS Sham (DEVICE), tACS 10Hz (DEVICE), tACS 20Hz (DEVICE).
Who is sponsoring clinical trial NCT06029075?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06029075's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy